Search results for Aedax

ADA and ADEX to Integrate Clinical Exam into Dental Licensure Test

The ADA and ADEX will integrate the ADA’s objective structured clinical exam into the ADEX Dental Examination by August 2026, aiming to streamline dental licensure and improve port...

Adeia Inc. (ADEA) Q1 2026 Earnings Call Transcript

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achiev...

- - • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency - • Efdoralpr...

Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation

Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug for this indication, and Axso...

Axonics

Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

<![CDATA[FDA Approves Auvelity for Treatment of Agitation Associated with Dementia Due to Alzheimers]]>

Axonics

Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension

AstraZeneca's Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with oth...

Applied Aerospace & Defense seeks $3.59 billion valuation in IPO

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Auvelity]]>